Literature DB >> 6742607

Sarcoidosis: epidemiology and prognosis. A 15-year European study.

G Hillerdal, E Nöu, K Osterman, B Schmekel.   

Abstract

A 15-year study of patients with sarcoidosis is presented. In most patients, the disease was discovered at a general health screening examination. The mean total incidence among persons 15 yr of age or older was 19 per 100,000 per year (21.7 for women and 16.5 for men). There was a peak incidence in both sexes between the ages of 20 and 34, and in older women, there was a second but lower and broader peak. The frequency of symptoms was greater in older women than in other patients. The accumulated lifetime risk of sarcoidosis was 1.3% for women and almost 1% for men. Patients with Stage I sarcoidosis, i.e., with bilateral hilar adenopathy alone, had the best prognosis, with 50% of the patients showing a normal radiographic picture 15 months after the discovery of the disease. Among patients with Stage II sarcoidosis (both bilateral hilar adenopathy and pulmonary infiltration), it was 36 months before 50% returned to normal radiographically. Resolution of all radiographic evidence of the disease could still occur many years after the first pathologic findings were made on chest films.

Entities:  

Mesh:

Year:  1984        PMID: 6742607     DOI: 10.1164/arrd.1984.130.1.29

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  79 in total

1.  Concomitant sarcoidosis and HIV infection.

Authors:  K S Gowda; I Mayers; S D Shafran
Journal:  CMAJ       Date:  1990-01-15       Impact factor: 8.262

2.  Outcome of pulmonary sarcoidosis: a population-based study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eva M Carmona; Eric L Matteson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

4.  Hydrogen peroxide release by alveolar macrophages from sarcoid patients and by alveolar macrophages from normals after exposure to recombinant interferons alpha A, beta, and gamma and 1,25-dihydroxyvitamin D3.

Authors:  A O Fels; C F Nathan; Z A Cohn
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

5.  Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua J Solomon; David Sprunger; Kevin K Brown
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

Review 6.  Cardiac sarcoidosis.

Authors:  Matthew M Zipse; William H Sauer
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

Review 7.  Gender disparities in ocular inflammatory disorders.

Authors:  Hatice Nida Sen; Janet Davis; Didar Ucar; Austin Fox; Chi Chao Chan; Debra A Goldstein
Journal:  Curr Eye Res       Date:  2014-07-02       Impact factor: 2.424

8.  Use of insurance claims data to determine prevalence and confirm a cluster of sarcoidosis cases in Vermont.

Authors:  Lori A Cragin; A Scott Laney; Cortland J Lohff; Brennan Martin; John A Pandiani; Lynn Z Blevins
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

9.  Pulmonary sarcoidosis with a diffuse ground glass pattern on the chest radiograph.

Authors:  A Tazi; T Desfemmes-Baleyte; P Soler; D Valeyre; A J Hance; J P Battesti
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

10.  Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women's Health Study.

Authors:  Yvette C Cozier; Jeffrey S Berman; Julie R Palmer; Deborah A Boggs; Lauren A Wise; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2012-09-11       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.